Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.


Journal

Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 25 9 2019
medline: 18 8 2020
entrez: 25 9 2019
Statut: ppublish

Résumé

Malignant bowel obstruction (MBO) is a common and distressing complication in women with advanced gynecologic cancer. A pilot, interprofessional MBO program was launched in 2016 at a large Canadian tertiary cancer center to integrate these patients' complex care needs across multiple disciplines and support women with MBO. Retrospective analysis to evaluate the outcomes of women with advanced gynecologic cancer who were admitted to hospital because of MBO, before (2014 to 2016: baseline group) and after (2016 to 2018) implementation of the MBO program. Of the 169 women evaluated, 106 and 63 were in the baseline group and MBO program group, respectively. Most had ovarian cancer (n = 124; 73%) and had small-bowel obstruction (n = 131; 78%). There was a significantly shorter cumulative hospital length of stay (LOS Implementation of a comprehensive, interprofessional MBO program significantly affects patient care and may improve outcomes. Unique to this MBO program is an integrated outpatient model of care and education that empowers patients to recognize MBO symptoms for early intervention.

Identifiants

pubmed: 31550202
doi: 10.1200/JOP.18.00793
pmc: PMC6911166
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1066-e1075

Références

Oncologist. 2009 Aug;14(8):835-9
pubmed: 19684071
Eur J Cancer. 2008 May;44(8):1105-15
pubmed: 18359221
Cancer. 2005 Feb 15;103(4):863-8
pubmed: 15641035
Ann Oncol. 2014 Feb;25(2):487-93
pubmed: 24406425
Gynecol Oncol. 2006 Oct;103(1):176-80
pubmed: 16564074
JPEN J Parenter Enteral Nutr. 2007 Nov-Dec;31(6):508-10
pubmed: 17947608
J Pain Symptom Manage. 2007 Jul;34(1 Suppl):S49-59
pubmed: 17544243
Am J Hosp Palliat Care. 2016 Apr;33(3):272-5
pubmed: 25552305
Int J Gynecol Cancer. 2017 Sep;27(7):1367-1372
pubmed: 28704322
Clin Nutr. 2015 Oct;34(5):825-37
pubmed: 25288565
Eur J Cancer Care (Engl). 2013 Jul;22(4):468-73
pubmed: 23730735
Cancer Med. 2016 Feb;5(2):239-47
pubmed: 26714799
Obstet Gynecol Int. 2018 May 17;2018:1867238
pubmed: 29887891
Cancer Manag Res. 2012;4:159-69
pubmed: 22904637
Future Oncol. 2017 Mar;13(6):513-521
pubmed: 28095701
Int J Gynecol Cancer. 2009 Jan;19(1):54-7
pubmed: 19258942
Gynecol Oncol. 2013 Apr;129(1):107-12
pubmed: 23274561
Nutrition. 2006 Apr;22(4):355-60
pubmed: 16413750

Auteurs

Yeh Chen Lee (YC)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Nazlin Jivraj (N)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Lisa Wang (L)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Tanya Chawla (T)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Jenny Lau (J)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Jennifer Croke (J)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Johane P Allard (JP)

University of Toronto, Toronto, ON, Canada.

Terri Stuart-McEwan (T)

Princess Margaret Cancer Centre, Toronto, ON, Canada.
University of Toronto, Toronto, ON, Canada.

Kashish Nathwani (K)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Valerie Bowering (V)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Katherine Karakasis (K)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Catherine O'Brien (C)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Eran Shlomovitz (E)

University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.

Sarah E Ferguson (SE)

Princess Margaret Cancer Centre, Toronto, ON, Canada.
University of Toronto, Toronto, ON, Canada.

Sarah Buchanan (S)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Pamela Ng (P)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Sunu Cyriac (S)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Lisa Tinker (L)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Neesha Dhani (N)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Amit M Oza (AM)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Stephanie Lheureux (S)

Princess Margaret Cancer Centre, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH